Nano24

Next-generation of Immunomodulators

Active Seed Startup Tel Aviv-Yafo Founded 2020-06

Website ↗ LinkedIn

The cytokine storm is the most severe complication of a wide range of pulmonary and systemic diseases with an urgent unmet need, leading to more than 60M patients with 15M deaths per year. Utilising two breakthroughs, CD24 (the drug), and Exosomes (the carrier), Nano24 has developed the next generation of immunomodulators proving to solve the cytokine storm…